Trial intelligence / Profile preview

SHAPE for Intracranial Pressure Assessment

NCT06571786Phase 2Completed

Sponsor
Thomas Jefferson University
Start
Dec 2024
Primary completion
Jul 2025
Modality
Drug Delivery Systems
Countries
1
01

Overview

A Phase 2 trial of perflutren lipid microspheres in idiopathic intracranial hypertension (IIH), intracranial hypertension (IH), sponsored by Thomas Jefferson University. Started Dec 2024; status: completed.

02

Drugs

perflutren lipid microspheres
03

Conditions

idiopathic intracranial hypertension (IIH)intracranial hypertension (IH)

Beyond the preview

Go deeper on NCT06571786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06571786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call